Japan Patent Office Grants Patent for SIRT6 Variants
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
What happened
The Japan Patent Office issued a Decision to Grant a patent application covering SIRT6 variants for use in preventing and treating age-related diseases, which includes 16 allowed claims. The patent application, titled "Variants of SIRT6 for use in preventing and/or treating ag[ing]," was granted by the Japan Patent Office. The University of Rochester owns the patent application.
From investegate.co.uk
Why it matters
The patent grant relates to gene therapies targeting the biology of ageing, a field in which Genflow Biosciences Plc is active. The news also notes that additional animal health companies have signed confidentiality agreements to evaluate Genflow's SIRT6 gene therapy.
From investegate.co.uk
Who's involved
- Japan Patent OfficeJapanese governmental agency that issued the Decision to Grant the patent
- University of RochesterUniversity that owns the patent application for SIRT6 variants
Keep exploring
The entities involved
-
Japan Patent Office
Japanese governmental agency
Nothing else this week.
-
University of Rochester
private, nonsectarian, research university in Rochester, New York, United States